In addition, this structure inhibits tumor cell growth by inhibiting multiple receptor tyrosine kinases, such as Vascular Endothelial Growth Factor Receptors (VEGFRs), Platelet-Derived Growth Factor Receptors (PDGFRs), and Epidermal Growth Factor Receptors (EGFRs) [17]. The gene discussed is NTRK1; the disease is neoplasm.